Union Korea Pharm. Co. Ltd.
Union Korea Pharm. Co. Ltd. operates in Pharmaceuticals.
Market Cap & Net Worth: Union Korea Pharm. Co. Ltd. (080720)
Union Korea Pharm. Co. Ltd. (KO:080720) has a market capitalization of $16.82K (₩24.63 Million) as of March 18, 2026. Listed on the KO stock exchange, this Korea-based company holds position #44121 globally and #2508 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Union Korea Pharm. Co. Ltd.'s stock price ₩2725.00 by its total outstanding shares 9039 (9.04K).
Union Korea Pharm. Co. Ltd. Market Cap History: 2018 to 2025
Union Korea Pharm. Co. Ltd.'s market capitalization history from 2018 to 2025. Data shows change from $75.57K to $16.82K (-23.10% CAGR).
Union Korea Pharm. Co. Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Union Korea Pharm. Co. Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 080720 by Market Capitalization
Companies near Union Korea Pharm. Co. Ltd. in the global market cap rankings as of March 18, 2026.
Key companies related to Union Korea Pharm. Co. Ltd. by market ranking:
- Sam Chun Dang Pharm. Co. Ltd (KQ:000250): Ranked #3465 globally with a market cap of $3.69 Billion USD ( ₩5.41 Trillion KRW).
- Mezzion Pharma Co.Ltd (KQ:140410): Ranked #6393 globally with a market cap of $1.27 Billion USD ( ₩1.86 Trillion KRW).
- ST Pharm Co.Ltd (KQ:237690): Ranked #7113 globally with a market cap of $1.05 Billion USD ( ₩1.54 Trillion KRW).
- Oscotec Inc (KQ:039200): Ranked #7795 globally with a market cap of $890.75 Million USD ( ₩1.30 Trillion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #3465 | Sam Chun Dang Pharm. Co. Ltd | KQ:000250 | $3.69 Billion | ₩739000.00 |
| #6393 | Mezzion Pharma Co.Ltd | KQ:140410 | $1.27 Billion | ₩89200.00 |
| #7113 | ST Pharm Co.Ltd | KQ:237690 | $1.05 Billion | ₩153400.00 |
| #7795 | Oscotec Inc | KQ:039200 | $890.75 Million | ₩54900.00 |
Union Korea Pharm. Co. Ltd. Historical Marketcap From 2018 to 2025
Between 2018 and today, Union Korea Pharm. Co. Ltd.'s market cap moved from $75.57K to $ 16.82K, with a yearly change of -23.10%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | ₩16.82K | 0.00% |
| 2024 | ₩16.82K | -44.95% |
| 2023 | ₩30.56K | -30.77% |
| 2022 | ₩44.14K | -29.56% |
| 2021 | ₩62.66K | -44.84% |
| 2020 | ₩113.59K | +43.29% |
| 2019 | ₩79.27K | +4.91% |
| 2018 | ₩75.57K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Union Korea Pharm. Co. Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $16.82K USD |
| MoneyControl | $16.82K USD |
| MarketWatch | $16.82K USD |
| marketcap.company | $16.82K USD |
| Reuters | $16.82K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.